Psychedelic Stocks Archives - Page 21 of 61

ThursdaySep 07, 2023 3:42 pm

Colorado Seeks Public Views on Implementing Psychedelic Decriminalization

Colorado officials will hold online hearings to gather public opinions on Colorado’s efforts to implement psychedelic decriminalization measures. The state became one of the first regions in the country to pass psychedelic policy after Colorado voters approved a measure to decriminalize several psychedelics for adults aged 21 years and older, setting the state on a path to legalize and regulate psilocybin “healing centers.” Colorado is now seeking public views on implementing psychedelic decriminalization in the state, specifically how the public believes a regulated psychedelic program should look and function. This includes how to train first responders to address psychedelic-related medical…

WednesdaySep 06, 2023 1:00 pm

Study Suggests MDMA Could Reduce Uncomfortable Effects of LSD, Psilocybin

Researchers from the Langone Center of Psychedelic Medicine at New York University and the Imperial College London’s Center for Psychedelic Research have published a study suggesting that small doses of MDMA could help reduce the uncomfortable effects of psilocybin and LSD. Psychedelics such as LSD and psilocybin (magic mushrooms) can produce feelings of euphoria and lead to life-changing insights, but they can also induce feelings of discomfort and anxiety in users. Bad trips, as they are referred to, are a relatively common occurrence among psychedelic users and are characterized by symptoms such as extreme paranoia, sudden and extreme mood swings,…

TuesdaySep 05, 2023 12:34 pm

Timothy Leary Expounds on Five Stages Psychedelic Users Could Experience During a Trip

Even though psychedelics have been illegal since the 1970s, psychedelic use among people has surged in recent years, partly due to claims of psychedelics’ therapeutic properties and the fact that younger generations are increasingly moving away from alcohol and tobacco. For people looking to try psychedelics for the first time, acquiring the relevant knowledge and making adequate preparation is the difference between having a positive and impactful psychedelic experience and a negative experience. With that in mind, American psychologist, author and psychedelic advocate Timothy Leary has broken down the psychedelic experience into five key stages or levels. Level 1 is…

FridaySep 01, 2023 1:34 pm

Indigenous People Fight to Retain Traditions of Psychedelic Use as Sacred Medicine

A group of indigenous peoples with a history of traditional and spiritual psychedelic use called the Native Coalition of Colorado protested its lack of involvement in psychedelic discussions during the recent psychedelic conference in Denver. Held during five days in Denver, the Psychedelic Science Conference attracted more than 11,000 attendees from various professions and covered everything from the therapeutic potential of psychedelics to psychedelic-related businesses. The conference was a major indication of America’s increasing acceptance of psychedelics in various industries and is a great indication of the future of psychedelics in America. However, Indigenous peoples who have been using psychedelics…

ThursdayAug 31, 2023 2:24 pm

Former California Firefighter Funding Psychedelic Retreats for State Firefighters

A retired firefighter from California is funding psychedelic retreats for firefighters to help address mental disorders they developed while on the job. Access to psychedelics in the United States is mostly limited to a small number of clinical studies, meaning that the vast majority of people who could benefit from psychedelic-assisted therapy never get the chance to try the treatment. Former Santa Clara County firefighter Angela Graham spent close to two decades as a firefighter, and her on-the-job experiences left her with extreme anxiety, uncontrollable anger and depression. Although she tried conventional mental-health treatments such as talk therapy, she didn’t…

WednesdayAug 30, 2023 3:08 pm

Study Suggests DMT Boosts Structural Neural Plasticity

A recent study published in the “Neuropsychopharmacology” journal has found that 5-MeO-DMT or DMT (5-methoxy-N, N-dimethyltryptamine) may boost structural neural elasticity. The article reported that, after giving mouse models 5-MeO-DMT, researchers found that the psychedelic caused an enduring increase in dendritic spine density in the brain’s medial frontal cortex. Researchers posit that the neural changes could be a counter to the changes caused by depression, adding to the growing body of studies pointing to psychedelics as potential mental-health treatments. DMT is a naturally occurring psychedelic found in certain species of seeds, toads and plants with a rich history of use…

TuesdayAug 29, 2023 1:33 pm

More Employers Including Psychedelic Therapy in Health Benefits Packages

Psychedelics have the potential to revolutionize psychiatry by significantly improving treatment outcomes and safety while minimizing side effects. A plethora of studies have revealed that hallucinogenic compounds such as psilocybin can be especially effective when combined with talk therapy, providing patients with immense relief against a myriad of mental-health conditions where conventional mental-health treatments weren’t fully effective. Although the field of psychedelic research is still quite young, it has delivered such impressive findings that lawmakers in several states are considering legalizing the therapeutic use of psychedelics against mental-health conditions. Some companies have even started covering psychedelic therapy in their employees'…

MondayAug 28, 2023 12:44 pm

Psychedelics Could Transform How People Age, Die

Psychedelics are poised to transform mental health and the psychiatry industry in major ways. A recent surge of psychedelic-related research and clinical trials has revealed that the federally controlled drug may have prolific mental health benefits, especially against conditions that don’t always respond to modern mental health treatments. When paired with talk therapy, psychedelics can deliver immense long-term benefits against mental conditions such as treatment-resistant depression, post-traumatic stress disorder (PTSD) and eating disorders. Furthermore, research has found that psychedelics have barely any adverse side effects and can offer long-term relief after only a few doses, making them significantly more effective…

FridayAug 25, 2023 12:33 pm

Canadian Survey Shows People Aren’t Talking to Doctors About Medical Use of Psychedelics

A recent Canadian survey has revealed that an increasing number of people are taking psychedelics for therapeutic purposes but aren’t discussing their psychedelic use with their doctors. The poll discovered that Canadians are specifically using hallucinogens to address mental health challenges but aren’t informing their physicians about the psychedelic use. Published in the “Journal of Psychoactive Drugs,” the survey found that the use of naturalistic psychedelics in Canada is common. However, there is little data about whether patients report their interactions with psychedelics to their clinicians. Psychedelics are the most recent beneficiaries of the multinational wave of drug reform that…

ThursdayAug 24, 2023 2:44 pm

Specialist Discusses Potential of Psychedelics in Athletes’ Mental Health

Recent scientific interest in psychedelics as alternative mental health treatments has raised questions on the application of hallucinogens in treating athletes’ mental health. Following decades of federal criminalization, we have entered an age of looser drug policies and even drug reform that has facilitated the research of previously controlled psychedelic substances such as psilocybin, MDMA and LSD. Although psychedelics are still controlled, more researchers are getting official approval to run studies and clinical trials testing the medical efficacy of psychedelics against various mental disorders. This research has revealed that psychedelic compounds can deliver significant long-term benefits against conditions such as…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks